Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.

Cooper, C L

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. [electronic resource] - Vaccine Aug 2004 - 3136-43 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

0264-410X

10.1016/j.vaccine.2004.01.058 doi


Adjuvants, Immunologic--adverse effects
Adult
Antibodies, Viral--analysis
Antibody Formation--immunology
Dose-Response Relationship, Immunologic
Double-Blind Method
Enzyme-Linked Immunosorbent Assay
Female
Hemagglutinins--analysis
Humans
Influenza Vaccines--administration & dosage
Interferon-alpha--analysis
Interferon-gamma--analysis
Male
Monocytes--metabolism
Oligodeoxyribonucleotides--adverse effects